LBO — NORTH CANYON MEDICAL CENTER
IRR: 23.6% | MOIC: 2.89x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
23.6%
IRR
2.89x
MOIC
$24.0M
Entry EV
$47.0M
Exit EV
$12.4M
Equity Invested
Sources & Uses
S&UTotal · $24.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $9.3M | 38.8% | |
| Sub Debt | $2.3M | 9.7% | |
| Equity | $12.4M | 51.5% | |
| Enterprise Value | $23.3M | 97.1% | |
| Transaction Fees | $0.7M | 2.9% | |
| Total Uses | $24.0M | 100.0% |
Interpretation
INTAt 2.89x MOIC and 23.6% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $4.5M |
| Exit Ev | $47.0M |
| Net Debt At Exit | $11.2M |
| Equity At Exit | $35.8M |
| Equity Invested | $12.4M |
| Total Value Created | $23.4M |
| Value From Growth | $22.5M |
| Value From Multiple | $1.2M |
| Value From Deleveraging | $0.4M |